Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transgenic mouse expressing a full-length hepatitis C virus cDNA

J Matsuda1, M Suzuki, C Nozaki

  • 1The Chemo-Sero-Therapeutic Research Institute, Kikuchi Research Center, Pathology Department, Kumamoto.

Japanese Journal of Cancer Research : Gann
|April 21, 1998
PubMed
Summary

Researchers created transgenic mice expressing Hepatitis C virus (HCV) to study the virus. One line showed low-level HCV expression and antibodies in the liver, offering a potential model for HCV research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vivo properties of KNT-127, a novel δ opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice.

British journal of pharmacology·2014
Same author

The nanostructure and hydrogenation reaction of Mg50Co50 BCC alloy prepared by ball-milling.

Nanotechnology·2009
Same author

Circadian clock molecules CLOCK and CRYs modulate fibrinolytic activity by regulating the PAI-1 gene expression.

Journal of thrombosis and haemostasis : JTH·2006
Same author

CLOCK is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression.

Journal of thrombosis and haemostasis : JTH·2006
Same author

Endoscope disinfection using chlorine dioxide in an automated washer-disinfector.

The Journal of hospital infection·2006
Same author

Aberrant regulation of imprinted gene expression in Gtl2lacZ mice.

Cytogenetic and genome research·2006

Area of Science:

  • Hepatology and Virology
  • Transgenic Animal Models
  • Viral Hepatitis Research

Background:

  • Hepatitis C virus (HCV) causes significant post-transfusion hepatitis.
  • Current models for HCV infection are limited, primarily to humans and chimpanzees.
  • Developing alternative models is crucial for understanding HCV pathogenesis.

Purpose of the Study:

  • To generate transgenic mouse models for studying Hepatitis C virus (HCV).
  • To investigate liver-specific expression of HCV components in vivo.
  • To assess the potential of these models for HCV research.

Main Methods:

  • Construction of transgenic mouse lines carrying full-length HCV cDNA.
  • Utilizing the human serum amyloid P component (hSAP) promoter for liver-specific gene expression.

Related Experiment Videos

  • Detection of HCV mRNA, HCV core protein, and HCV-related antibodies in transgenic mice.

    • Main Results:

    • Nine transgenic mouse lines were successfully produced.
    • One line exhibited detectable, albeit low-level, expression of HCV mRNA and core protein in the liver.
    • HCV-specific antibodies were identified in the serum of the transgenic mice.

    Conclusions:

    • Transgenic mice can be engineered to express Hepatitis C virus components.
    • Low-level expression and antibody production suggest a potential, though limited, in vivo model.
    • Further development may be needed to enhance expression for robust HCV research.